TY - JOUR
T1 - A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility
T2 - Guidelines from the kidney precision medicine project
AU - Kidney Precision Medicine Project
AU - El-Achkar, Tarek M.
AU - Eadon, Michael T.
AU - Menon, Rajasree
AU - Lake, Blue B.
AU - Sigdel, Tara K.
AU - Alexandrov, Theodore
AU - Parikh, Samir
AU - Zhang, Guanshi
AU - Dobi, Dejan
AU - Dunn, Kenneth W.
AU - Otto, Edgar A.
AU - Anderton, Christopher R.
AU - Carson, Jonas M.
AU - Luo, Jinghui
AU - Park, Chris
AU - Hamidi, Habib
AU - Zhou, Jian
AU - Hoover, Paul
AU - Schroeder, Andrew
AU - Joanes, Marianinha
AU - Azeloglu, Evren U.
AU - Sealfon, Rachel
AU - Winfree, Seth
AU - Steck, Becky
AU - He, Yongqun
AU - D’agati, Vivette
AU - Iyengar, Ravi
AU - Troyanskaya, Olga G.
AU - Barisoni, Laura
AU - Gaut, Joseph
AU - Zhang, Kun
AU - Laszik, Zoltan
AU - Rovin, Brad H.
AU - Dagher, Pierre C.
AU - Sharma, Kumar
AU - Sarwal, Minnie M.
AU - Hodgin, Jeffrey B.
AU - Alpers, Charles E.
AU - Kretzler, Matthias
AU - Jain, Sanjay
N1 - Publisher Copyright:
© 2021 the American Physiological Society.
PY - 2021
Y1 - 2021
N2 - Comprehensive and spatially mapped molecular atlases of organs at a cellular level are a critical resource to gain insights into pathogenic mechanisms and personalized therapies for diseases. The Kidney Precision Medicine Project (KPMP) is an endeavor to generate three-dimensional (3-D) molecular atlases of healthy and diseased kidney biopsies by using multiple state-of-the-art omics and imaging technologies across several institutions. Obtaining rigorous and reproducible results from disparate methods and at different sites to interrogate biomolecules at a single-cell level or in 3-D space is a significant challenge that can be a futile exercise if not well controlled. We describe a “follow the tissue” pipeline for generating a reliable and authentic single-cell/region 3-D molecular atlas of human adult kidney. Our approach emphasizes quality assurance, quality control, validation, and harmonization across different omics and imaging technologies from sample procurement, processing, storage, shipping to data generation, analysis, and sharing. We established benchmarks for quality control, rigor, reproducibility, and feasibility across multiple technologies through a pilot experiment using common source tissue that was processed and analyzed at different institutions and different technologies. A peer review system was established to critically review quality control measures and the reproducibility of data generated by each technology before their being approved to interrogate clinical biopsy specimens. The process established economizes the use of valuable biopsy tissue for multiomics and imaging analysis with stringent quality control to ensure rigor and reproducibility of results and serves as a model for precision medicine projects across laboratories, institutions and consortia.
AB - Comprehensive and spatially mapped molecular atlases of organs at a cellular level are a critical resource to gain insights into pathogenic mechanisms and personalized therapies for diseases. The Kidney Precision Medicine Project (KPMP) is an endeavor to generate three-dimensional (3-D) molecular atlases of healthy and diseased kidney biopsies by using multiple state-of-the-art omics and imaging technologies across several institutions. Obtaining rigorous and reproducible results from disparate methods and at different sites to interrogate biomolecules at a single-cell level or in 3-D space is a significant challenge that can be a futile exercise if not well controlled. We describe a “follow the tissue” pipeline for generating a reliable and authentic single-cell/region 3-D molecular atlas of human adult kidney. Our approach emphasizes quality assurance, quality control, validation, and harmonization across different omics and imaging technologies from sample procurement, processing, storage, shipping to data generation, analysis, and sharing. We established benchmarks for quality control, rigor, reproducibility, and feasibility across multiple technologies through a pilot experiment using common source tissue that was processed and analyzed at different institutions and different technologies. A peer review system was established to critically review quality control measures and the reproducibility of data generated by each technology before their being approved to interrogate clinical biopsy specimens. The process established economizes the use of valuable biopsy tissue for multiomics and imaging analysis with stringent quality control to ensure rigor and reproducibility of results and serves as a model for precision medicine projects across laboratories, institutions and consortia.
KW - Imaging
KW - Kidney disease
KW - Metabolomics
KW - Proteomics
KW - Transcriptomics
UR - http://www.scopus.com/inward/record.url?scp=85099721196&partnerID=8YFLogxK
U2 - 10.1152/physiolgenomics.00104.2020
DO - 10.1152/physiolgenomics.00104.2020
M3 - Article
C2 - 33197228
AN - SCOPUS:85099721196
SN - 1094-8341
VL - 53
SP - 1
EP - 11
JO - Physiological genomics
JF - Physiological genomics
IS - 1
ER -